方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01521 方达控股

已收盘 05-06 14:53:28

0.990

+0.010

+1.02%

最高0.990	最低0.970	成交量20.20万
今开0.980	昨收0.980	日振幅2.04%
总市值20.18亿	流通市值20.18亿	总股本20.38亿
成交额19.80万	换手率0.01%	流通股本20.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01521","market":"HK","secType":"STK","nameCN":"方达控股","latestPrice":0.99,"timestamp":1778050408878,"preClose":0.98,"halted":0,"volume":202000,"delay":0,"changeRate":0.01020408163265307,"floatShares":2038000000,"shares":2038000000,"eps":0.0033,"marketStatus":"已收盘","change":0.01,"latestTime":"05-06 14:53:28","open":0.98,"high":0.99,"low":0.97,"amount":198040,"amplitude":0.020408,"askPrice":1,"askSize":476000,"bidPrice":0.97,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.025678,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778117400000},"marketStatusCode":5,"adr":0,"listingDate":1559145600000,"exchange":"SEHK","adjPreClose":0.98,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":1.729452,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01521","defaultTab":"news","newsList":[{"id":"1191478174","title":"方达控股季度净利润报290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191478174","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191478174?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:47","pubTimestamp":1777376862,"startTime":"0","endTime":"0","summary":"方达控股公司最新财报显示，本季度实现净利润290万美元。这一业绩数据反映了公司在当前财季的盈利表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","LU1820825898.SGD","BK1141","BK0077","BK0028","300347","BK1583","BK1576","01521","LU1146622755.USD","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630050583","title":"方达控股(01521)一季度纯利约290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630050583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630050583?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:17","pubTimestamp":1777375036,"startTime":"0","endTime":"0","summary":"智通财经APP讯，方达控股 发布公告，于截至2026年3月31日止3个月，集团取得纯利约290万美元，而2025年同期则取得亏损净额约90万美元;收益约6790万美元，同比增加18.9%。经扣除以股份为基础的薪酬开支、并购所得无形资产摊销及并购相关开支后，集团的经调整纯利约为500万美元，较2025年同期约160万美元增加212.5%。于2026年3月31日，集团的未经审核综合资产净值约为3.518亿美元，而于2025年12月31日则约为3.346亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","01521","BK1576","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180125675","title":"方达控股2025年稳步扩张：收入小幅增长并成功扭亏为盈，持续强化全球研发生态布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1180125675","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180125675?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:37","pubTimestamp":1777369044,"startTime":"0","endTime":"0","summary":"方达控股在截至2025年12月31日止年度实现收入256,691千美元，较2024年的254,907千美元增长0.7%。期内毛利为69,199千美元，毛利率约27%，与上年度相近。除税前溢利从2024年的2,744千美元大幅增至11,587千美元，增长322.3%，净利润则由上年度的亏损619千美元转为溢利6,762千美元，净利率升至2.6%。经调整纯利为15,698千美元，同比提升18.5%。管理层表示，盈利回升主要得益于核心业务表现改善及费用管控成效提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"方达控股2025年稳步扩张：收入小幅增长并成功扭亏为盈，持续强化全球研发生态布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168030105","title":"方达控股授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1168030105","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168030105?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:36","pubTimestamp":1777369013,"startTime":"0","endTime":"0","summary":"方达控股公告显示，公司拟于2026年6月2日召开股东周年大会，审议授予董事一般及无条件授权，以回购公司不超过已发行股份总数的10%。据披露，截至最后实际可行日期，公司已发行股份总数为2,034,488,910股，若此次购回授权获通过并于有效期内获全部行使，方达控股可回购最多203,448,891股。方达控股将于2026年5月27日至6月2日暂停办理股份过户登记，以确定有资格出席股东周年大会并投票的股东。董事会同时建议股东于会议上审慎行使表决权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"方达控股授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1154903192","title":"方达控股更新3月股份变动月报表，发行股本增至20.38亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154903192","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154903192?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:56","pubTimestamp":1775725010,"startTime":"0","endTime":"0","summary":"方达控股于2026年4月9日披露，截至2026年3月31日的月报表显示，公司本月发行股本由2,036,024,910股增加至2,037,524,910股，增幅为1,500,000股。注册股本维持在5,000,000,000股。公告显示，本月主要变动来自公司股份期权计划的行使，合计行使期权产生1,500,000股普通股，所得资金约为576,000港元。截至3月底，方达控股已发行股份总数增至2,037,524,910股，库存股份数目为零。公司声明继续符合香港联交所《上市规则》及现行法律规定的最低公众持股量要求。该公告由方达控股执行董事兼主席李松签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623630314","title":"方达控股(01521)发布年度业绩 股东应占溢利679.3万美元 同比增长758.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623630314","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623630314?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:21","pubTimestamp":1774869671,"startTime":"0","endTime":"0","summary":"智通财经APP讯，方达控股(01521)发布截至2025年12月31日止年度业绩，该集团取得收益2.57亿美元，同比增长0.7%;公司拥有人应占溢利679.3万美元，同比增长758.8%;每股基本盈利0.0034美元。公告称，北美及欧洲业务收益略有减少，主要由于药物发现业务产生的收益下降所致。此乃受到制药及生物技术公司持续优化研发组合及谨慎控制开发支出的负面影响。然而，实验室检测服务相当强劲的需求部分抵销了该跌幅。中国业务的收益增长主要由于产能利用率有所提升及集团在营销方面的努力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1583","BK1576","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632075","title":"方达控股（1521.HK）完成对观合医药收购，进一步强化全球中心实验室能力布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632075","media":"全景网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632075?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:00","pubTimestamp":1772766000,"startTime":"0","endTime":"0","summary":"2026年3月3日，泰格医药集团旗下方达控股宣布已正式完成对观合医药的收购。此次收购将进一步完善方达在全球中心实验室领域的布局，强化其在中国及亚太地区的综合服务能力。此次收购也是方达控股持续推进全球化布局的重要举措。方达控股始终坚守“全球同一质量体系”的准则，获得的试验数据支持多国申报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1161","BK1574","09939","01521","BK1515","BK1583","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185861883","title":"方达控股完成收购Teddy Lab，强化全球中心实验室服务能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1185861883","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185861883?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:28","pubTimestamp":1772638091,"startTime":"0","endTime":"0","summary":"方达控股（股票代码：01521）近日宣布，已完成对Teddy Lab的收购交易。此次收购将显著增强方达控股在全球范围内的中心实验室服务能力，进一步提升其在国际医药研发服务领域的竞争力。通过整合Teddy Lab的专业资源，方达控股有望扩大服务范围，为全球客户提供更高效、更全面的医药研发解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1583","01521","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115013752","title":"方达控股（01521）2026年2月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1115013752","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115013752?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:06","pubTimestamp":1772611588,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年3月4日发布截至2026年2月28日的股份变动月报。公司本月底已发行普通股总数继续保持在2,036,024,910股，库存股份为0股，总体股本无新增发行或注销变化。报告期内，首次公开发售前股份激励计划期权维持16,950,000份；2018年股份激励计划由16,550,500份期权减少至16,227,500份，系部分期权注销或失效所致。目前公司已发行股份总数仍保持稳定，公允持股量符合相关上市规则要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616465673","title":"方达控股(01521)附属完成收购上海观合医药科技股份有限公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2616465673","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616465673?lang=zh_cn&edition=full","pubTime":"2026-03-03 18:29","pubTimestamp":1772533759,"startTime":"0","endTime":"0","summary":"智通财经APP讯，方达控股(01521)发布公告，就有关本公司全资附属公司方达上海拟2.7亿元收购上海观合医药科技股份有限公司(目标公司)的相关事宜。股份转让协议所载的所有先决条件均已达成，且根据股份转让协议的条款及条件，交割已于2026年3月3日作实。交割后，目标公司已成为本公司全资附属公司，而目标公司及其附属公司的财务业绩将综合入账至本集团财务报表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1141","01521","BK1574","09939","BK1576","BK1515","BK1583","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175934174","title":"方达控股（1521）2026年1月股份变动月报，小幅增发300,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1175934174","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175934174?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:19","pubTimestamp":1770196757,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年2月4日发布截至2026年1月31日的股份变动月报。报告显示，公司注册股本维持在5,000,000,000股，面值每股USD 0.00001，总额USD 50,000，未发生变化。截至2026年1月31日，公司已发行股份总数2,036,024,910股，相比上月2,035,724,910股，净增300,000股。月报同时提及公司此前进行过若干股份购回，合计3,536,000股尚处于“拟注销但尚未注销”状态，未对本月已发行股份总数造成进一步影响。方达控股公司声明已遵守香港联交所《上市规则》及其他相关法律法规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607263777","title":"方达控股盘中异动 大幅上涨5.05%报1.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607263777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607263777?lang=zh_cn&edition=full","pubTime":"2026-01-28 13:19","pubTimestamp":1769577543,"startTime":"0","endTime":"0","summary":"2026年01月28日下午盘13时19分，方达控股股票出现波动，股价大幅上涨5.05%。截至发稿，该股报1.040港元/股，成交量8.4万股，换手率0.00%，振幅6.06%。资金方面，该股资金流入2080港元，流出8.12万港元。方达控股股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，嘉和生物、复宏汉霖、腾盛博药-B涨幅较大，振幅较大的相关个股有旺山旺水-B、嘉和生物、银诺医药-B，振幅分别为12.49%、11.86%、9.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128131903953eab8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128131903953eab8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01521","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605478919","title":"方达控股01月23日主力净流出33.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605478919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605478919?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156130,"startTime":"0","endTime":"0","summary":"01月23日, 方达控股股价跌3.85%，报收1.00元，成交金额191.1万元，换手率0.10%，振幅11.54%，量比30.59。方达控股今日主力资金净流出33.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.67%，主力资金累计净流出33.4万元；近20日主力资金累计净流入5.8万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161820a44d85a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161820a44d85a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1583","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604618111","title":"方达控股中美一体化CDMO全面投产，为创新药全球商业化赋能","url":"https://stock-news.laohu8.com/highlight/detail?id=2604618111","media":"环球财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604618111?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:48","pubTimestamp":1768816136,"startTime":"0","endTime":"0","summary":"近日，美通社PR Newswire发布，方达美国总部位于宾夕法尼亚州Exton的CDMO GMP生产基地已于2025年10月顺利完成GMP验证，并正式进入全面运营阶段。在中国，方达同步布局 CDMO 制造与研发能力，目前在苏州已建成超过 9,000 平方米的研发与cGMP生产空间，具备多剂型制剂开发与生产能力。方达控股始终坚守“全球同一质量体系”的准则，获得的试验数据支持多国申报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119181900a72c0aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119181900a72c0aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","BK1576","06978","BK1161","BK1574","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161482462","title":"方达控股（1521）更新2025年12月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1161482462","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161482462?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:46","pubTimestamp":1767689188,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年1月6日公布2025年12月股份变动月报表。公告显示，截至2025年12月31日，公司注册股本维持为5,000,000,000股，面值每股0.00001美元，对应注册股本总额50,000美元。已发行股份总数继续保持在2,035,724,910股，未见新增发行或注销。此前曾于2024年5月28日购回合计3,536,000股普通股，但尚未注销，故本月股本总数仍维持稳定。截至2025年12月底，公司完整股本结构及合规状况保持良好。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137631776","title":"方达控股（1521）更新11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1137631776","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137631776?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:50","pubTimestamp":1764838235,"startTime":"0","endTime":"0","summary":"方达控股公司于2025年12月4日发布截至2025年11月30日的股份变动月报表。公司注册股本5,000,000,000股，每股面值0.00001美元，注册股本总额50,000美元；期内未见变动，保持不变。公司本月底已发行普通股与上月底一致，仍为2,035,724,910股，报告期内无新增发行，也未见任何注销动作。截至11月末，公司股本规模总体维持稳定。公司声明已遵守香港联交所《上市规则》及相关法律规定，公告由执行董事兼主席李松签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589535798","title":"方达控股12月04日主力净流入21.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535798","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589535798?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836147,"startTime":"0","endTime":"0","summary":"12月04日, 方达控股股价涨2.91%，报收1.06元，成交金额21.2万元，换手率0.01%，振幅0.00%，量比1.08。方达控股今日主力资金净流入21.2万元，上一交易日主力净流出0万元。该股近5个交易日上涨1.92%，主力资金累计净流入21.2万元；近20日主力资金累计净流入34.7万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161956a7234fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161956a7234fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1576","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585196913","title":"方达控股盘中异动 股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585196913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585196913?lang=zh_cn&edition=full","pubTime":"2025-11-21 10:47","pubTimestamp":1763693226,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘10时47分，方达控股股票出现波动，股价大幅下挫5.50%。截至发稿，该股报1.030港元/股，成交量14.6万股，换手率0.01%，振幅8.26%。方达控股股票所在的生物技术行业中，整体跌幅为4.83%。其相关个股中，帝王国际投资、派格生物医药-B、盛禾生物-B涨幅较大，振幅较大的相关个股有华康生物医学、百奥赛图-B、加科思-B，振幅分别为12.50%、12.06%、11.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121104706a4b07d7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121104706a4b07d7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01521","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518790064","title":"方达控股03月11日主力净流出32万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518790064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518790064?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:15","pubTimestamp":1741680920,"startTime":"0","endTime":"0","summary":"03月11日，方达控股股价收平报1.04元，成交金额179万元，换手率0.09%，振幅16.35%，量比1.94。方达控股今日主力资金净流出32万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.78%，主力资金累计净流出32万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入57万元，其中净流入天数为3日。该股主力净额占比0.01%，港股市场排名2468/2656。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165333a1d49b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165333a1d49b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","01521","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518731963","title":"方达控股股价重挫14.42% 市值跌2.47亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518731963?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:30","pubTimestamp":1741656632,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时30分，方达控股股票出现异动，股价大幅下挫14.42%。截至发稿，该股报0.890港元/股，成交量55.2万股，换手率0.03%，振幅7.69%。资金方面，该股资金流入2.49万港元，流出47.276万港元。方达控股股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，荃信生物-B、东曜药业-B、百济神州涨幅较大，振幅较大的相关个股有方达控股、科伦博泰生物-B、来凯医药-B，振幅分别为7.69%、6.59%、4.57%。该公司的部门包括北美和欧洲以及中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110930329640c93c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110930329640c93c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","01521","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.frontagelab.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1091},{"period":"3month","weight":-0.0667},{"period":"6month","weight":-0.1171},{"period":"1year","weight":-0.1171},{"period":"ytd","weight":-0.02}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.0311},{"period":"3month","weight":-0.0353},{"period":"6month","weight":-0.0222},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.0105}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Frontage Holdings Corp是一家控股公司。该公司为制药和农用化学品公司提供实验室和相关服务，以及生物等效性临床和化学服务。该公司有两个分部。全球实验室服务部门为参与药物开发的客户提供实验室测试支持。全球药物发现与开发服务部门包括药物开发部门、药物发现部门和药品开发部门。其全球实验室服务涵盖受监管和非受监管的生物分析（小分子和大分子）、生物标志物、基因组学、制造和控制分析测试以及中央实验室服务。药物开发部门包括药物代谢和药代动力学、安全性和毒理学。该公司的业务分部包括北美和欧洲以及中国。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.028193},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.020831},{"month":3,"riseRate":0,"avgChangeRate":-0.123558},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.028258},{"month":5,"riseRate":0.428571,"avgChangeRate":0.041051},{"month":6,"riseRate":0.428571,"avgChangeRate":0.022378},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.005506},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.051658},{"month":9,"riseRate":0.285714,"avgChangeRate":0.018408},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.03842},{"month":11,"riseRate":0.571429,"avgChangeRate":0.091516},{"month":12,"riseRate":0.714286,"avgChangeRate":0.124365}],"exchange":"SEHK","name":"方达控股","nameEN":"FRONTAGE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方达控股,01521,方达控股股票,方达控股股票老虎,方达控股股票老虎国际,方达控股行情,方达控股股票行情,方达控股股价,方达控股股市,方达控股股票价格,方达控股股票交易,方达控股股票购买,方达控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}